NR4A1 and neoplasm: In a subsequent genome-wide transcript expression analysis of 99 primary breast cancer samples and eight cell lines, Doane et al. identified ten (of 41) hormone receptor negative tumours with paradoxical expression of AR and multiple other genes, known to be ER targets or typically expressed in ER positive tumours [62].